FDA Approved: TACROLIMUS — Original Application (BPI Labs LLC)

View source ↗

Summary

The FDA approved an original application for tacrolimus from BPI Labs LLC, authorizing a generic tacrolimus product to prevent organ transplant rejection. Tacro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

ORIG AP for TACROLIMUS (TACROLIMUS)